Cytokinetics | CYTK - Debt

Stock Price
61.85
Daily Change
-1.67 -2.63%
Monthly
-4.26%
Yearly
33.96%
Q1 Forecast
61.24

Cytokinetics reported $858.06M in Debt for its fiscal quarter ending in June of 2025.





Debt Change Date
Acadia Pharmaceuticals USD 56.29M 1.36M Jun/2025
Amgen USD 54.59B 1.62B Sep/2025
Bayer EUR 39.39B 1.31B Mar/2025
Biogen USD 6.29B 309.5M Sep/2025
Bristol-Myers Squibb USD 51.04B 112M Sep/2025
Cytokinetics USD 858.06M 199.93M Jun/2025
Eisai JPY 187.52B 31.58B Mar/2025
Eli Lilly USD 42.51B 2.6B Sep/2025
Geron USD 121.84M 3.12M Jun/2025
Halozyme Therapeutics USD 1.51B 1.65M Jun/2025
Ionis Pharmaceuticals USD 1.23B 192.99M Sep/2025
Ligand Pharmaceuticals USD 5.74M 5.72M Jun/2025
Merck USD 41.37B 5.97B Sep/2025
Novartis USD 32.64B 1.37B Jun/2025
Pfizer USD 60.85B 78M Sep/2025
Regeneron Pharmaceuticals USD 2.71B 400K Sep/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Sanofi EUR 21.76B 530M Sep/2025